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The goal of this study was to retrospectively review the magnetic resonance imaging (MRI) features 
of retroperitoneal extra-adrenal paragangliomas and to evaluate the diagnostic capabilities of MRI. 
Twenty-four patients with confirmed benign retroperitoneal extra-adrenal paragangliomas who 
underwent preoperative MRI and surgical resection were enrolled. The patients’ clinical characteristics 
and MRI features were reviewed by two radiologists. There were no significant differences in the 
qualitative and quantitative MRI features were determined by the reviewers. High signal intensity in T2-
weighted imaging (T2WI) and diffusion-weighted imaging (DWI) was observed in all tumors. In contrast 
T1-weighted imaging (T1WI) in the arterial phase, 83.33% of the tumors were clearly enhanced. In 
87.5% of cases, a persistent enhancement pattern was observed in the venous and delayed phases, 
and 12.5% of tumors showed a “washout” pattern. The tumor capsule, intratumoral septum and 
degenerations were visualized in the tumors and may be helpful in the qualitative diagnosis of extra-
adrenal paragangliomas in MRI. MRI was useful in locating the position, determining the tumor ranges 
and visualizing the relationship between the tumors and adjacent structures. The presence of typical 
clinical symptoms and positivity of biochemical tests are also important factors in making an accurate 
preoperative diagnosis.
Primary neurogenic tumors, which constitute 10% to 20% of primary retroperitoneal tumors, typically occur at 
younger ages and are usually benign1. Retroperitoneal extra-adrenal paragangliomas account for 1–3% of retrop-
eritoneal tumors, originate in the paraganglionic system and are the most common benign soft-tissue tumors2, 3. 
Extra-adrenal pheochromocytomas are also referred to as ectopic pheochromocytomas or paragangliomas. In 
the abdominal cavity, extra-adrenal pheochromocytomas occur primarily in the retroperitoneum, the organ of 
Zuckerkandl, and the urinary bladder4, 5.
Although patients diagnosed with retroperitoneal extra-adrenal pheochromocytomas typically present with 
hypertension, tachycardia, headache and diaphoresis6, other tumors may be completely clinically silent and are 
only detected incidentally in imaging studies; these tumors are referred to as “incidentalomas”. Any physical con-
tact with these tumors can precipitate cardiac arrhythmias and malignant hypertension7. This is the most impor-
tant reason why urologists and radiologists should, now more than ever, understand the imaging appearance of 
paragangliomas. Because the MR imaging features of most retroperitoneal soft-tissue masses are nonspecific, the 
prediction of a specific histologic diagnosis remains a radiographic challenge. To our knowledge, a description of 
the MRI features of retroperitoneal extra-adrenal paragangliomas has been reported for only studies with small 
sample sizes; therefore, the purpose of our study was to retrospectively analyze the MRI features of benign retro-
peritoneal extra-adrenal paragangliomas.
Results
Demographic data and clinical characteristics. A total of 24 retroperitoneal extra-adrenal paragan-
glioma lesions in 24 patients were included in this study (Figs 1 and 2). The presenting clinical characteristics of 
these patients are summarized in Table 1. Ten tumors were found incidentally in 24 patients. Urinary catechola-
mine (CA) and 24-h urinary vanillylmandelic acid (VMA) concentrations were measured in 22 patients, and 9 
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tested positive. Eleven patients had hypertension, which was paroxysmal in 3 cases; 3 patients presented with the 
typical symptoms of pheochromocytoma, including palpitations, headache and diaphoresis. No patient had a his-
tory of primary adrenal tumor or other tumors. The mean delay between MRI and surgery was 21 ± 7 days. The 
tumors were fully excised in all cases, with clear resection margins. The final histologic diagnosis was obtained by 
laparoscopic surgery (n = 9), robot-assisted laparoscopic surgery (n = 10), or laparotomy (n = 5).
Imaging features in MRI Scans. The presenting quantitative MR imaging characteristics of mean maxi-
mum lesion size, diameter ratio and Apparent Diffusion Coefficient (ADC) values of the 24 patients are summa-
rized in Table 2; there were no significant differences between the assessments made by the two reviewers. Among 
the 24 lesions, a maximum diameter greater than 5 cm was observed in 17 cases; in the remaining 7 lesions, the 
maximum diameter was less than 5 cm.
Figure 1. A 49-year-old asymptomatic man with incidentaloma and a histologically proven benign 
retroperitoneal paraganglioma at the right prevertebral region (between the inferior vena cava and aorta). 
The transverse and longitudinal diameters of the tumor are 2.61 cm and 3.13 cm, respectively. (A) in axial 
T2-weighted imaging, the tumor demonstrates high signal intensity and isointensity compared with the 
gluteal muscles. The intratumoral cystic areas exhibit higher signal intensity. (B) In axial DWI, the tumor 
exhibits ring-shaped high signal intensity. (C–E) T1-weighted imaging (in-phase, out-phase and pre-scanned 
imaging, respectively); the signal of the tumor is slightly lower than that of the gluteal muscle. (F) In contrast 
T1-weighted imaging during the arterial phase, the tumor is clearly enhanced and non-homogeneous. (G) In 
coronal T1-weighted imaging during the delay phase, the tumor is clearly enhanced and non-homogeneous. 
(H) ADC imaging; the mean ADC value of the ROI of the tumor is 0.00147 mm2/s.
Figure 2. A 47-year-old man with incidentaloma and a histologically proven benign retroperitoneal 
paraganglioma at the right prevertebral region (among the inferior vena cava, pars horizontalis duodeni and 
aorta). The transverse and longitudinal diameters of the tumor are 3.92 cm and 3.72 cm, respectively. (A) In axial 
T2-weighted imaging, the tumor demonstrates high signal intensity and isointensity compared with the gluteal 
muscles. (B) In axial DWI, the tumor appears with nodular high signal intensity compared with the spleen.  
(C–E) T1-weighted images (in-phase, out-phase and pre-scanned imaging, respectively); the signal of the tumor 
is slightly lower than that of the gluteal muscle. (F) In contrast T1WI during the arterial phase, the tumor is 
clearly enhanced and non-homogeneously ring-shaped. The center exhibits no enhancement of the necrotic 
area. (G) In coronal T1WI during the delay phase, the tumor shows a continuous and non-homogeneous signal 
increase. (H) ADC imaging; the mean ADC value of the ROI of the tumor is 0.00180 mm2/s.
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Findings regarding the qualitative MR imaging features:
 (1) No statistically significant differences were recorded between the reviewers in lesion location, shape, 
boundary, microscopic fat, or subacute hemorrhage findings (Table 3). The concordance of the two review-
ers for each of the assessed features ranged from good to excellent (from 91.67% to 95.83%) (Table 4).
 (2) The results showed that 54.17% of the paragangliomas were located in the prevertebral region, which is 
close to the aorta and inferior vena cava; no retroperitoneal extra-adrenal paragangliomas were observed 
in the pelvis.
 (3) In T1WI, the tumor signal was similar to that of muscle in fat-suppressed T1WI. The signal was hetero-
geneous in all tumors; areas of less intense signal were observed, pathologically representing necrosis or 
cysts. Subacute hemorrhage was detected within the tumors of 12 patients (Fig. 3), and microscopic fat was 
detected in the tumors of 3 patients.
 (4) In T2WI, the tumor signal was much more intense than that of the muscle and liver in fat-suppressed 
T2WI; in 13 cases, the signal intensity was much higher than that of the spleen; in 6 cases, it was lower; and 
5 cases demonstrated equal signals. One paraganglioma demonstrated a fluid-fluid level inside the lesion 
(Fig. 4).
 (5) In DWI, the high signal intensity of tumors was heterogeneous; the signal intensity of 13 tumors was much 
higher than that of the spleen; in 6 cases, it was lower; and in 5 cases, the signal was equal. The shape of the 
high signal was ring-shaped (n = 11 cases), nodular (n = 5), or a slice (n = 8).
 (6) More than 80% of the tumors were round or oval, and more than 60% of the tumor boundaries were 
well-defined. None of the tumors demonstrated infiltrating or encapsulating phenomena. However, the 
pushing and shifting of nearby structures, such as the pancreas, kidney, inferior vena cava and abdominal 
aorta, were found for larger tumors.
MR Imaging features of dynamic enhancement. 
 (1) No statistically significant differences were recorded between the reviewers in terms of necrosis, cystic 
degeneration or degree of tumor enhancement (Table 3).
 (2) All tumors showed non-homogeneous enhancement after gadolinium administration, with a non-en-
hancing component showing a fluid signal or necrotic component and peripheral enhancement of the 
solid elements. Twenty tumors were clearly enhanced in contrast T1WI in the arterial phase. The degree of 
Characteristic Paraganglioma group (n = 24)
No. of patients (female) 24 (12)
*Age (years) 48.04 ± 9.70
Hypertension (n) 11
CA-related symptoms (n) 3
Asymptomatic (n) 10
VMA/24 h (Positive) 22 (9)
CA/24 h (Positive) 22 (9)
131I-MIBG positive 9
Other symptoms
    Abdominal mass (n) 2
    Lumbago (n) 3
    Dysuria (n) 0
Resection of tumor
    Laparoscopic surgery (n) 9
    Robot-assisted laparoscopic surgery (n) 10
    Laparotomy (n) 5
Table 1. Patient demographics and clinical characteristics. Note: *Values are mean values ± standard 
deviations. Other data are numbers of patients (n). CA-related symptoms: catecholamine-related symptoms. 
VMA: vanillylmandelic acid. CA: catecholamine. MIBG: Metaiodobenzylguanidine scintigraphy.
Parameter Reader 1 Reader 2 P value
Tumor maximum size (cm) 5.61 ± 2.11 5.70 ± 2.10 0.875
Diameter ratio (TD/LD) 0.878 ± 0.145 0.855 ± 0.144 0.585
Mean ADC value (×10−3 mm2/s) 1.541 ± 0.425 1.565 ± 0.425 0.849
Table 2. Quantitative characteristics of retroperitoneal extra-adrenal paragangliomas. Note: Values are mean 
values ± standard deviations. P values were calculated using t tests. Diameter ratio = Mean TD (transverse 
diameter)/Mean LD (longitudinal diameter). ADC: Apparent Diffusion Coefficient.
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enhancement of 21 paragangliomas showed a continuous signal increase of mass in the venous and delayed 
phases (a persistent pattern), whereas only 3 paragangliomas showed “washout” of signal intensity.
 (3) Cysts and necrosis, which were seen in 24 patients, were divided into three types based on their MR appear-
ance8. The first type was characterized by the presence of several small cysts that were separately distributed 
in the solid tumors (n = 11). The second type was characterized by cysts or/and necrosis located in the 
centers of tumors (n = 9). The third type was characterized by cysts or necrosis comprising most of the 
tumor with an irregular wall thickness (n = 5). None of the cysts or necrosis were enhanced in contrast MRI.
Imaging Feature Reader 1 Reader 2 P value
Location
    Right paravertebral region 8.33 (2/24) 8.33 (2/24)
1.000
    Left paravertebral region 37.5 (9/24) 41.67 (10/24)
    Prevertebral region 54.17 (13/24) 50 (12/24)
    Pelvic cavity 0 (0) 0 (0)
Shape
    Round or oval 83.33 (20/24) 87.5 (21/24)
1.000
    Irregular 16.67 (4/24) 12.5 (3/24)
Boundaries
    Well-defined 66.67 (16/24) 70.83 (17/24)
1.000
    Partly poorly defined 33.33 (8/24) 29.17 (7/24)
Microscopic fat
    YES 12.5 (3/24) 16.67 (4/24)
1.000
    NO 87.5 (21/24) 83.33 (20/24)
Subacute hemorrhage
    YES 54.17 (13/24) 50 (12/24)
1.000
    NO 45.83 (11/24) 50 (12/24)
High signal in DWI
    Higher 54.17 (13/24) 54.17 (13/24)
1.000    Lower 29.17 (7/24) 25 (6/24)
    Equal 16.67 (4/24) 20.83 (5/24)
Necrosis
    YES 75 (18/24) 70.83 (17/24)
1.000
    NO 25 (6/24) 29.17 (7/24)
Cysts
    YES 62.5 (15/24) 66.67 (16/24)
1.000
    NO 37.5 (9/24) 33.33 (8/24)
Degree of tumor enhancement
    Avid enhancement 41.67 (10/24) 33.33 (8/24)
0.926    Moderate enhancement 41.67 (10/24) 50 (12/24)
    Slight enhancement 16.67 (4/24) 16.67 (4/24)
Table 3. Frequency of assessed imaging features in retroperitoneal extra-adrenal paragangliomas. Note: Data 
are percentages with raw numbers of patients (n) in parenthesis. P values were calculated using χ2 tests. Higher: 
the high signal of the tumor in DWI is higher than that of the spleen. Lower: the high signal of the tumor in 
DWI is lower than that of the spleen. Equal: the high signal of the tumor in DWI is equivalent to that of the 
spleen.
Attribute Concordance
Location 91.67 (22/24)
Shape 95.83 (23/24)
Tumor boundaries 95.83 (23/24)
Microscopic fat 95.83 (23/24)
Subacute hemorrhage 95.83 (23/24)
Necrosis 95.83 (23/24)
Cystic degeneration 95.83 (23/24)
Degree of tumor enhancement 91.67 (22/24)
Table 4. Comparison of the Concordance between Readers for Each Assessed Qualitative Imaging Feature. 
Note: Values are percentages with raw numbers of patients (n) in parentheses.
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 (4) The intratumoral septa, which were uneven in thickness, were shown in T2WI with low or equal signal 
intensity and in non-enhanced T1WI with slightly low signal intensity (n = 15); the septa were enhanced in 
contrast MRI.
 (5) The tumor capsule was observed in 15 cases in T2WI and in 10 cases in T1WI; the capsule was enhanced in 
contrast MRI (n = 17).
Figure 3. A 60-year-old man with hypertension, positive VMA/24 h and a histologically proven benign 
retroperitoneal paraganglioma at the right prevertebral region (between the inferior vena cava and aorta). The 
transverse and longitudinal diameters of the tumor are 2.89 cm and 4.43 cm, respectively. (A) In axial T2WI, 
the tumor exhibits high signal intensity and isointensity compared with the gluteal muscles. The intratumoral 
septa exhibit low signal intensity. The tumor capsule is shown in T2WI. (B) In axial DWI, the tumor appears 
nodular with ring-shaped high signal intensity. (C–E) In T1WI (in-phase, out-phase and pre-scanned imaging, 
respectively), the partial signal of the tumor is higher than that of the gluteal muscle, and most of the signal 
of the tumor is of slightly lower intensity than that of gluteal muscle. (F) In contrast T1WI during the arterial 
phase, the tumor is clearly enhanced with a non-homogeneous ring. The center exhibits no enhancement of the 
necrotic area and cysts. (G) In coronal T1WI during the delay phase, the tumor exhibits a continuous and non-
homogeneous signal increase. The intratumoral septa show a continuous signal increase. (H) ADC imaging; the 
mean ADC value of the ROI of the tumor is 0.00152 mm2/s.
Figure 4. A 53-year-old woman with dizziness and hypertension and a histologically proven benign 
retroperitoneal paraganglioma at the left paravertebral region (adjacent to the left adrenal gland). The transverse 
and longitudinal diameters of the tumor are 8.04 cm and 9.71 cm, respectively. (A) In axial T2WI, the tumor 
exhibits mixed signal intensity, including high signal intensity, slightly high signal intensity, and isointensity, 
compared with the gluteal muscles. The signs of fluid-fluid levels can be seen. The intratumoral septa exhibit 
low signal intensity. (B) In axial DWI, the tumor appears with a ring of high signal intensity. (C–E) In T1WI 
(in-phase, out-phase and pre-scanned imaging, respectively), the signal of the tumor is slightly lower than that 
of the gluteal muscle in in-phase imaging and pre-scanned imaging, and exhibits a linear and sheet-like high 
signal in out-phase imaging. (F) In contrast T1WI during the arterial phase, the tumor exhibits slight and non-
homogeneous enhancement. The center exhibits no enhancement of the necrotic area. (G) In coronal T1WI 
during the delay phase, the tumor is slightly enhanced. (H) ADC imaging; the mean ADC value of the ROI of 
the tumor is 0.00130 mm2/s.
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Preoperative Diagnostic MRI Findings
The correct preoperative diagnosis of extra-adrenal paraganglioma was made in 75% (18/24) of cases; a diagnosis 
of incomplete certainty was made in 20.83% (5/24) of cases, and a misdiagnosis was made in one case (4.17%) 
(Table 5).
Discussion
Retroperitoneal extra-adrenal paragangliomas confined to the retroperitoneum are frequently encountered in 
clinical practice; however, the clinical presentation is often misleading or even absent, and thus diagnostic diffi-
culties are often encountered9. To our knowledge, our study includes the largest series to date describing the MRI 
features of benign retroperitoneal extra-adrenal paragangliomas with DWI and dynamic contrast-enhanced MRI 
(DCE-MRI).
Many imaging features associated with paragangliomas were observed in the MRI examination. In our study, 
more than 50% of extra-adrenal paragangliomas were situated in the prevertebral region close to the inferior vena 
cava and aorta following the aorta-sympathetic chain, consistent with results from previous reports4, 5, 10.
Patients Hypertension
CA-related 
symptoms VMA/24 h CA/24 h 131I-MIBG Location
Degree of tumor 
enhancement
Preoperative diagnosis of 
MRI
1 + − − − + Left paravertebral region Slight enhancement
Retroperitoneal extra-adrenal 
paragangliomas
2 − − + + + Prevertebral region Moderate enhancement Retroperitoneal extra-adrenal paragangliomas
3 + − + + + Prevertebral region Moderate enhancement Retroperitoneal extra-adrenal paragangliomas
4 + − + + + Prevertebral region Slight enhancement Retroperitoneal extra-adrenal paragangliomas
5 + − − − + Prevertebral region Moderate enhancement Retroperitoneal extra-adrenal paragangliomas
6 + + + + + Prevertebral region Avid enhancement Retroperitoneal extra-adrenal paragangliomas
7 + − + + + Left paravertebral region Avid enhancement
Retroperitoneal extra-adrenal 
paragangliomas
8 + + + + + Prevertebral region Moderate enhancement Retroperitoneal extra-adrenal paragangliomas
9 + − − − + Prevertebral region Avid enhancement Retroperitoneal extra-adrenal paragangliomas
10 + + + + − Prevertebral region Avid enhancement Retroperitoneal extra-adrenal paragangliomas
11 − − − − N.A. Prevertebral region Moderate enhancement
Giant lymph node hyperplasia 
and retroperitoneal extra-
adrenal paragangliomas
12 − − + + − Left paravertebral region Slight enhancement Neurogenic tumor
13 − − − − − Left paravertebral region Slight enhancement
Retroperitoneal extra-adrenal 
paragangliomas
14 − − − − N.A. Right paravertebral region Moderate enhancement Neurogenic tumor
15 − − − − − Prevertebral region Avid enhancement Retroperitoneal extra-adrenal paragangliomas
16 + − + + − Prevertebral region Avid enhancement Retroperitoneal extra-adrenal paragangliomas
17 − − − − N.A. Left paravertebral region Moderate enhancement
Retroperitoneal extra-adrenal 
paragangliomas
18 − − − − N.A. Prevertebral region Avid enhancement
Stromal tumor and 
retroperitoneal extra-adrenal 
paragangliomas
19 − − − − N.A. Left paravertebral region Moderate enhancement
Retroperitoneal extra-adrenal 
paragangliomas
20 − − − − N.A. Left paravertebral region Avid enhancement
Retroperitoneal extra-adrenal 
paragangliomas
21 − − − − N.A. Right paravertebral region Avid enhancement
Retroperitoneal extra-adrenal 
paragangliomas
22 − − − − N.A. Prevertebral region Moderate enhancement Neurogenic tumor
23 − − − − N.A. Left paravertebral region Moderate enhancement Solid pseudopapillary tumor
24 − − − − N.A. Left paravertebral region Avid enhancement
Retroperitoneal extra-adrenal 
paragangliomas
Table 5. Major clinical data, MR imaging features and diagnostic findings. Note: −, negative; +, positive; N.A., 
not applicable.
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Paragangliomas have been described as masses with characteristically high signal intensity or a light 
bulb-bright signal in T2WI with fat suppression11. However, some studies have proposed that this feature is nei-
ther specific nor sensitive and may lead to the misdiagnosis of paragangliomas in up to 35% of cases4, 12. The high 
signal intensity is generally thought to be related to the extensive vascular supply of tumors and tumor cells13, 14; 
Dam et al.15 have proposed that the high signal intensity may be related to tumor catecholamine secretion. 
Furthermore, we observed that 13 cases had obviously higher signal intensity than that of the spleen in T2WI. 
The DWI of 13 cases represents the first report of cases in which the high signal intensity is much higher than that 
of the spleen, and the mean ADC values of all tumors were greater than those of neck paragangliomas16, 17. DWI 
assessment may, therefore, be of significant value for differential diagnosis.
Cyst degeneration, necrosis, subacute hemorrhage and calcifications are common in retroperitoneal extra-adrenal 
paragangliomas; all these findings tend to be observed in retroperitoneal tumors18. Necrotic change was observed in 
more than 70% of the tumors in our study and tended to occur as paragangliomas increased in size19. Brennan et al. 
reported hemorrhagic areas in paragangliomas20. Microscopic fat has not been reported in the literature and was not 
considered a specific feature. Calcifications can occur in all types of neurogenic tumors, without obvious specificity21.
DCE-MRI has also been used for tumor detection and characterization and is helpful in distinguishing ret-
roperitoneal extra-adrenal paragangliomas from other retroperitoneal tumors. In our study, 80% of retroperito-
neal extra-adrenal paragangliomas exhibited a strong initial signal increase during the arterial phase, consistent 
with results from other studies22, 23. The enhancement features of retroperitoneal paragangliomas in the venous and 
delayed phases have not previously been reported. Necrotic changes and cysts led to poor central enhancement but 
exhibited avid peripheral enhancement. Using DCE-MRI, tumor septa of different thicknesses (with low or equal 
signal intensity in 66.67% of cases in T2WI) demonstrated strong enhancement. Furthermore, we found that MRI 
was able to distinguish complete from incomplete capsules, thus providing useful information indicating that the 
tumor has a clear margin that separates it from the surrounding structures. However, it was unclear whether the 
tumor septa and capsule were characteristics of extra-adrenal paragangliomas in the retroperitoneum; further stud-
ies are necessary to confirm that these imaging features are useful for the diagnosis of paragangliomas.
Before surgery, the diagnosis was incorrect in one case (4.17%) on the basis of the MRI examination; a diagno-
sis with incomplete certainty was made in 20.83% of cases. The major factors for this uncertainty included ignor-
ing less-common locations of extra-adrenal paragangliomas, unfamiliarity with different MR tumor appearances, 
and the absence of typical clinical symptoms and signs.
Our study has several limitations. First, this was a retrospective study with a relatively small sample size for 
benign retroperitoneal extra-adrenal paragangliomas, thus reflecting the low incidence of this tumor type. The 
imaging features observed in our patients were similar to those described in other radiological series, and the 
small number of cases reflects the rarity of this tumor type. Second, the images reviewed were obtained using 
different MR instruments using two different field strengths; however, the same imaging protocols were used. 
Although we demonstrated that field strength had no effect on the ADC measurement of renal tumors between 
1.5 T and 3.0 T, we did not include many retroperitoneal tumors; however, this lack should not have significantly 
affected the imaging features studied. Furthermore, the ADC of various types of retroperitoneal lesions should be 
compared between 1.5 T and 3.0 T. Third, the lesions presented with predominantly cystic changes, hemorrhage 
and necrosis, which may have affected the ADC value or signal intensity measurement. Finally, the study included 
no malignant paragangliomas. We did not conduct a further study to differentiate benign from malignant retro-
peritoneal paraganglioma tumors.
In conclusion, the high signal intensity in T2WI and DWI, DCE-MRI features, the capsule, the intratumoral 
septum and degeneration may be helpful in the diagnosis of retroperitoneal extra-adrenal paragangliomas based 
on MRI. Typical clinical symptoms and positive biochemical tests are also very important in making accurate 
preoperative diagnoses. Qualitative and quantitative analyses of MRI features play an important role in accurately 
locating and diagnosing these tumors.
Materials and Methods
Patients. This retrospective study was approved by the PLA General Hospital review board, and informed 
consent was waived due to its retrospective nature. All methods were performed in accordance with the approved 
guidelines. Pathology and radiology databases were searched to identify all cases of histologically proven retrop-
eritoneal extra-adrenal paragangliomas in which 24 patients had undergone preoperative MRI between July 2008 
and February 2016; all patients had undergone surgical resection. The patients’medical histories were reviewed. 
The search identified 24 patients (12 men and 12 women, mean age: 48.04 ± 9.70 years, age range: 27–67 years) 
who had a total of 24 benign retroperitoneal extra-adrenal paragangliomas.
Magnetic Resonance Imaging Protocol. MRI examinations were conducted using a 1.5-T system (n = 2, 
Signa HDXT, GE Healthcare), a 3.0-T system (n = 16, Signa EXCITE; GE Healthcare) and a 3.0-T system (n = 6, 
Discovery 750, GE Healthcare). Patients were imaged in the supine position using a surface phased-array coil. 
Respiratory-triggered transverse and coronal T2-weighted fast spin-echo sequences were initially performed, 
and this was followed by transverse T1-weighted dual-echo in-phase and out-of-phase sequences and by 
three-dimensional fat-saturated T1-weighted dynamic contrast-enhanced sequences that were performed dur-
ing suspended respiration. Gadobenate dimeglumine (MultiHance; Bracco Sine, Shanghai, China) (15 mL) was 
injected intravenously at a rate of 2 mL/sec using a power injector (Spectris; MedRad, Warrendale, PA), and this 
was followed by a 20-mL saline flush. DCE-MRI was performed in the transverse plane at baseline (pre-contrast) 
and during the arterial, venous, and delayed phases. Transverse breath-hold DW images were obtained using a 
single-shot, spin-echo echo-planar sequence before the administration of contrast material with tri-directional 
gradients and two b values: 0 and 800 s/mm2.
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The MR imaging parameters were as follows: T2-w FSE images were acquired using the following parameters: 
infinite/90–105 ms (repetition time ms/echo time ms); field of view (FOV), 36–44 cm; section thickness, 5 mm; 
intersection gap, 1 mm; and matrix, 320 × 224. T1-w dual-echo images were acquired using the following param-
eters: 260/(2.2–2.5; 5.5–5.8) ms; FOV, 36–44 cm; section thickness, 5 mm; intersection gap, 1 mm; and matrix, 
256 × 192. For the 3D dynamic contrast-enhanced sequences, the following parameters were used: 3.0–3.9/1.2–
1.6 ms; FOV, 34–40 cm; section thickness, 5 mm; interpolated section thickness, 2.5 mm; and matrix, 288 × 224. 
DWI (5400/50–60 ms; flip angle, 90°; FOV, 36–40 cm; matrix, 128 × 128; section thickness, 5 mm; intersection 
gap, 1 mm; all directions; one signal acquired) was performed before the DCE-MRI with b values of 0 and 800 s/
mm2.
Imaging Analysis
All images were independently reviewed by two radiologists who had 10 and 5 years of experience in the interpre-
tation of abdominal MR images. The two reviewers were blinded to the histologic diagnoses of the lesions at the 
time of their review. The reviewers evaluated and recorded each lesion for the presence of each of the following 
features24, 25:
Quantitative MR Image Analysis:
 (a) Tumor maximum size: the size of each lesion was measured at its single largest diameter in three planes.
 (b) Diameter ratio: two reviewers independently measured the maximum transverse diameter (TD) and the 
longitudinal diameter (LD) of the mass in coronal section. The means of the maximum TD and LD of the 
mass in coronal section were recorded. Each measurement was conducted three times, and the mean value 
was used as the final value to avoid intra- and inter-observer disagreement. The diameter ratio was calcu-
lated using the following equation: Diameter ratio = Mean TD/Mean LD.
 (c) ADC values: ADC maps were auto-generated, and region-of-interest (ROI) analysis was performed using 
an Advantage Workstation (Advantage Workstation, version 4.6, GE Healthcare, Bue, France). ROIs were 
placed according to the most obvious enhancing region of the retroperitoneal tumors in the arterial phase 
according to visual assessment, with the aim of avoiding necrosis, hemorrhage and cystic changes (cysts 
are defined as the part of the lesion showing no enhancement in DCE-MR images). In each patient and for 
each tumor, three ROIs, each measuring 30–60 mm2, were drawn on three target anatomical structures. 
The mean ADC values in the ROIs on the three targets were calculated for each patient.
Qualitative MR Image Analysis (The analysis was based on the following parameters):
 (1) Position and peripheral location: lesions were determined to be located in the right or left paravertebral re-
gion (near the spinal column and psoas muscle, adrenal region or kidney), anterior to the vertebrae (close 
to the abdominal aorta and inferior vena cava, the origin of the inferior mesenteric artery or peripancreatic 
location) or in the pelvic cavity.
 (2) Shape: Tumors were determined to be round/oval or irregular.
 (3) Margin: Tumors were determined to be well-defined or partly poorly defined.
 (4) High signal in DWI: The shape of the high signal was divided into nodulars, ring and flaky signal. The sig-
nal intensity was compared with that of the spleen in DWI and assessed to be higher, lower, or equivalent 
to that of the spleen.
 (5) Microscopic lipid: The area of signal loss in the lesion in out-of-phase T1-weighted images was 
determined.
 (6) Subacute hemorrhage: The area of increased T1 signal intensity in unenhanced fat-suppressed T1-weight-
ed images was determined.
 (7) Cystic degeneration: Areas with signal intensity (SI) equal to that of the cerebrospinal fluid in T2-weighted 
images, low SI in T1-weighted images, lack of enhancement, and lobulated morphology were assessed.
 (8) Necrosis: The presence of high SI in T2-weighted images (although not as high as the SI of cerebrospinal 
fluid), low SI in T1-weighted images, lack of enhancement, and central location within the tumor were 
assessed.
 (9) Degree of tumor enhancement: MR imaging was subjectively assessed regarding the degree of mass 
enhancement compared with that of the renal cortex (avid enhancement, moderate enhancement or slight 
enhancement) based on Gd-enhanced MR images acquired during the arterial phase.
 (10) Other MR imaging features were also assessed: intratumoral septa, tumor capsule, fluid-fluid level, subjec-
tive assessment of the MR imaging degree and the pattern of mass enhancement during the venous phase 
and delayed phase.
Pathologic Diagnosis. All specimens were retrospectively examined by two uropathologists with 10 years 
of experience in uropathology who were blinded to the MRI findings and who reached consensus.
Statistical Analysis
Continuous variables were expressed as the means ± SD and were analyzed using independent t-tests for nor-
mally distributed data or Mann-Whitney tests for non-normally distributed data. For qualitative variables, Chi 
square tests were used to compare the sample proportions of the two readers. Kappa coefficients were not used 
for this determination because the very high prevalence of certain imaging features for many of the binary factors 
was expected to produce misleadingly low values24, 26. All reported P values are two-sided and were considered 
statistically significant at values of less than 0.05. SPSS version 19.0 software was used for all computations.
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